Castlerock Clinical Research Consultants,LLC

Tulsa, Oklahoma 74136

0 studies enrolling now · 7 studies all time

What they study most

Atrial Fibrillation, Atrial Flutter, Diabetes Mellitus, Type 2, Gout, Hyperlipidemia, Hypertension, Irritable Bowel Syndrome, Paroxysmal Atrial Fibrillation

Studies at this site

• CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed
• A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation — Stopped early
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study) — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension — Stopped early
• Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome — Completed